These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 9191765
1. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E. Neurology; 1997 Jun; 48(6):1550-6. PubMed ID: 9191765 [Abstract] [Full Text] [Related]
2. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Am J Hum Genet; 2001 Mar; 68(3):686-99. PubMed ID: 11179016 [Abstract] [Full Text] [Related]
3. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. Sleep; 1997 Nov; 20(11):1012-20. PubMed ID: 9456467 [Abstract] [Full Text] [Related]
4. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Hong SC, Lin L, Jeong JH, Shin YK, Han JH, Lee JH, Lee SP, Zhang J, Einen M, Mignot E. Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989 [Abstract] [Full Text] [Related]
5. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. Alaez C, Lin L, Flores-A H, Vazquez M, Munguia A, Mignot E, Haro R, Baker H, Gorodezky C. BMC Med Genet; 2008 Aug 15; 9():79. PubMed ID: 18706091 [Abstract] [Full Text] [Related]
6. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Mignot E, Kimura A, Lattermann A, Lin X, Yasunaga S, Mueller-Eckhardt G, Rattazzi C, Lin L, Guilleminault C, Grumet FC, Mayer G, Dement WC, Underhill P. Tissue Antigens; 1997 Apr 15; 49(4):329-41. PubMed ID: 9151385 [Abstract] [Full Text] [Related]
7. [Narcolepsy-cataplexy]. Deflandre E, Roelants F, Cambron L, Poirrier R. Rev Med Liege; 2002 Aug 15; 57(8):519-27. PubMed ID: 12405025 [Abstract] [Full Text] [Related]
8. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients. Huang YS, Tafti M, Guilleminault C. Sleep Med; 2006 Aug 15; 7(5):454-7. PubMed ID: 16815745 [Abstract] [Full Text] [Related]
9. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S. Arch Neurol; 2002 Oct 15; 59(10):1553-62. PubMed ID: 12374492 [Abstract] [Full Text] [Related]
10. HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy. Hayduk R, Flodman P, Spence MA, Erman MK, Mitler MM. Sleep; 1997 Oct 15; 20(10):850-7. PubMed ID: 9415944 [Abstract] [Full Text] [Related]
11. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E. Sleep Med; 2003 Jan 15; 4(1):7-12. PubMed ID: 14592354 [Abstract] [Full Text] [Related]
12. Narcolepsy and HLA in the Japanese. Juji T, Matsuki K, Tokunaga K, Naohara T, Honda Y. Ann N Y Acad Sci; 1988 Jan 15; 540():106-14. PubMed ID: 2905117 [Abstract] [Full Text] [Related]
13. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Sleep; 2002 Feb 01; 25(1):27-35. PubMed ID: 11833858 [Abstract] [Full Text] [Related]
14. [Diagnosis of childhood narcolepsy and significance of HLA in its diagnosis]. Wu HS, Guo YH, Zou LP, Han F, Zhang WC, Fang F, Xiao J, Ding CH, Li J, Chen CH. Zhonghua Er Ke Za Zhi; 2004 Apr 01; 42(4):248-51. PubMed ID: 15157381 [Abstract] [Full Text] [Related]
15. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, Underhill P, Guilleminault C, Dement WC, Grumet FC. Sleep; 1994 Dec 01; 17(8 Suppl):S60-7. PubMed ID: 7701202 [Abstract] [Full Text] [Related]
16. Association Study of HLA-DQB1*0602 Allele in Iranian Patients with Narcolepsy. Geremew D, Rahimi-Golkhandan A, Sadeghniiat-Haghighi K, Shakiba Y, Khajeh-Mehrizi A, Ansaripour B, Izad M. Iran J Allergy Asthma Immunol; 2017 Oct 01; 16(5):452-456. PubMed ID: 29149785 [Abstract] [Full Text] [Related]
17. Familial aspects of narcolepsy-cataplexy in the Czech Republic. Nevsímalová S, Mignot E, Sonka K, Arrigoni JL. Sleep; 1997 Nov 01; 20(11):1021-6. PubMed ID: 9456468 [Abstract] [Full Text] [Related]
18. Use of PCR with sequence-specific primers for high-resolution human leukocyte antigen typing of patients with narcolepsy. Woo HI, Joo EY, Hong SB, Lee KW, Kang ES. Ann Lab Med; 2012 Jan 01; 32(1):57-65. PubMed ID: 22259780 [Abstract] [Full Text] [Related]
19. Severity of narcolepsy among French of different ethnic origins (south of France and Martinique). Dauvilliers Y, Bazin M, Ondzé B, Bera O, Bazin M, Besset A, Billiard M. Sleep; 2002 Feb 01; 25(1):50-5. PubMed ID: 11833861 [Abstract] [Full Text] [Related]
20. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1( *)1501/DQB1( *)0602 finding. Sasai T, Inoue Y, Komada Y, Sugiura T, Matsushima E. Sleep Med; 2009 Oct 01; 10(9):961-6. PubMed ID: 19410508 [Abstract] [Full Text] [Related] Page: [Next] [New Search]